- Home
- AUTL vs FLX Comparison
AUTL vs FLX Comparison
Compare AUTL & FLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- FLX
- Stock Information
- Founded
- AUTL 2014
- FLX 2013
- Country
- AUTL United Kingdom
- FLX China
- Employees
- AUTL N/A
- FLX N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- FLX
- Sector
- AUTL Health Care
- FLX
- Exchange
- AUTL Nasdaq
- FLX NYSE
- Market Cap
- AUTL 625.4M
- FLX N/A
- IPO Year
- AUTL 2018
- FLX 2024
- Fundamental
- Price
- AUTL $2.47
- FLX $3.32
- Analyst Decision
- AUTL Strong Buy
- FLX
- Analyst Count
- AUTL 5
- FLX 0
- Target Price
- AUTL $9.32
- FLX N/A
- AVG Volume (30 Days)
- AUTL 1.8M
- FLX 86.7K
- Earning Date
- AUTL 08-07-2025
- FLX 08-27-2025
- Dividend Yield
- AUTL N/A
- FLX N/A
- EPS Growth
- AUTL N/A
- FLX N/A
- EPS
- AUTL N/A
- FLX N/A
- Revenue
- AUTL $9,011,000.00
- FLX $595,490,250.00
- Revenue This Year
- AUTL $461.76
- FLX N/A
- Revenue Next Year
- AUTL $112.66
- FLX N/A
- P/E Ratio
- AUTL N/A
- FLX N/A
- Revenue Growth
- AUTL N/A
- FLX N/A
- 52 Week Low
- AUTL $1.11
- FLX $2.01
- 52 Week High
- AUTL $5.00
- FLX $21.95
- Technical
- Relative Strength Index (RSI)
- AUTL 69.22
- FLX N/A
- Support Level
- AUTL $2.24
- FLX N/A
- Resistance Level
- AUTL $2.53
- FLX N/A
- Average True Range (ATR)
- AUTL 0.13
- FLX 0.00
- MACD
- AUTL -0.00
- FLX 0.00
- Stochastic Oscillator
- AUTL 88.55
- FLX 0.00
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.